1260TiP The efficacy of the addition of TRAstuzumab and Pertuzumab to neoadjuvant chemoradiation: A randomized multi-center study in resectable HER2 overexpressing adenocarcinoma of the esophagus or gastroesophageal junction (TRAP-2)

Autor: D. Blangé, M.C.C.M. Hulshof, M.I. van Berge Henegouwen, B. Mostert, M. Slingerland, N. Haj Mohammad, M.C. Grootscholten, G-J.M. Creemers, L.J.M. Mekenkamp, E. Fiets, J.J. De Haan, P. Jeene, T. Rozema, M. Berbee, A. Beeker, L.V. Beerepoot, S. Derks, M.F. Bijlsma, N. van Grieken, H.W.M. van Laarhoven
Rok vydání: 2022
Předmět:
Zdroj: Annals of Oncology. 33:S1123-S1124
ISSN: 0923-7534
DOI: 10.1016/j.annonc.2022.07.1378
Databáze: OpenAIRE